Menendez Alvarado LR, Margulis Landayan A, Williams KN, Frederick CM, et al. Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections. J Antimicrob Chemother 2024 May 8:dkae135. doi: 10.1093.
PMID: 38717472